Calculation of your study is finished. Please find your results below.

A study for a 77 year old woman who takes Entresto, Xarelto (an AI-powered real world drug study)

Summary:

187 females aged 77 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 77 year old female patient who has Cfs. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 15, 2026

187 females aged 77 (±5) who take Entresto, Xarelto and have adverse effects are studied.


Number of reports submitted per year:

Entresto, Xarelto for a 77-year old woman.

Information of the patient in this study:

  • Age: 77
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Side Pain:
    - among females aged 77 (±5) who take the same drugs: 0% (0 of 187)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 2,139)

By each condition:

  • people who have Side Pain with Cfs:
    - among females aged 77 (±5) who have Cfs: 0% (0 of 18)
    - among people who have Cfs, regardless of gender or age: 0% (0 of 818)

By each drug (FDA data only):

  • people who take Entresto and have Side Pain:
    - among females aged 77 (±5) who take Entresto and have side effects: 0.02% (1 of 4,021)
    - among people who take Entresto and have side effects, regardless of gender or age: 0.03% (42 of 126,188)
  • people who take Xarelto and have Side Pain:
    - among females aged 77 (±5) who take Xarelto and have side effects: 0.01% (3 of 22,399)
    - among people who take Xarelto and have side effects, regardless of gender or age: 0.05% (107 of 210,296)

Common drug interactions *:

  1. Dyspnea (difficult or laboured breathing): 58 people, 31.02%
  2. Chest Pain : 36 people, 19.25%
  3. Hypotension (abnormally low blood pressure): 32 people, 17.11%
  4. Weakness : 28 people, 14.97%
  5. Cardiac Failure : 22 people, 11.76%
  6. Oedema Peripheral (superficial swelling): 21 people, 11.23%
  7. Fatigue (feeling of tiredness): 19 people, 10.16%
  8. Fall : 19 people, 10.16%
  9. Malaise (a feeling of general discomfort or uneasiness): 15 people, 8.02%
  10. Arrhythmias (irregular heartbeat): 14 people, 7.49%
  11. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 14 people, 7.49%
  12. Cough : 13 people, 6.95%
  13. Dyspnea Exertional : 13 people, 6.95%
  14. Abdominal Pain Upper : 12 people, 6.42%
  15. General Physical Health Deterioration (weak health status): 12 people, 6.42%
  16. Pneumonia : 12 people, 6.42%
  17. High Blood Pressure : 11 people, 5.88%
  18. Gait Disturbance : 11 people, 5.88%
  19. Nausea And Vomiting : 11 people, 5.88%
  20. Panic Reaction : 11 people, 5.88%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Cardiac Failure : 41 people, 21.93%
  2. High Blood Pressure : 17 people, 9.09%
  3. Cardiac Disorder : 12 people, 6.42%
  4. Cardiac Failure Chronic : 10 people, 5.35%
  5. Cardiac Failure Congestive : 9 people, 4.81%
  6. Diabetes : 9 people, 4.81%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 3.74%
  8. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 3.74%
  9. Thyroid Diseases : 7 people, 3.74%
  10. High Blood Cholesterol : 7 people, 3.74%
  11. Blood Pressure Abnormal : 7 people, 3.74%
  12. Arrhythmias (irregular heartbeat): 5 people, 2.67%
  13. Dyslipidaemia (abnormal amount of lipids): 5 people, 2.67%
  14. Anaemia (lack of blood): 5 people, 2.67%
  15. Nausea (feeling of having an urge to vomit): 4 people, 2.14%
  16. Cardiac Amyloidosis (protein deposition in heart): 4 people, 2.14%
  17. Pain : 4 people, 2.14%
  18. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 2.14%
  19. Cardiomyopathy (weakening of the heart muscle): 4 people, 2.14%
  20. Insomnia (sleeplessness): 4 people, 2.14%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Spironolactone (44 people, 23.53%)
  2. Torsemide (35 people, 18.72%)
  3. Lasix (28 people, 14.97%)
  4. Pantoprazole (23 people, 12.30%)
  5. Amlodipine (23 people, 12.30%)
  6. Allopurinol (23 people, 12.30%)
  7. Mirtazapine (22 people, 11.76%)
  8. Furosemide (16 people, 8.56%)
  9. Carvedilol (16 people, 8.56%)
  10. Aspirin (15 people, 8.02%)
  11. Jardiance (14 people, 7.49%)
  12. Metformin (13 people, 6.95%)
  13. Paracetamol (13 people, 6.95%)
  14. Clopidogrel (12 people, 6.42%)
  15. Tapentadol (11 people, 5.88%)
  16. Levothyroxine Sodium (11 people, 5.88%)
  17. Metoprolol Succinate (11 people, 5.88%)
  18. Pregabalin (11 people, 5.88%)
  19. Alendronic Acid (11 people, 5.88%)
  20. Plavix (10 people, 5.35%)

Drug effectiveness *:

Entresto:

n/a

Xarelto:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drug interactions:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: